MedCath Profits in 3Q - Analyst Blog
August 15 2011 - 9:01AM
Zacks
Heath care services provider MedCath
Corporation’s (MDTH) third-quarter fiscal 2011 adjusted
(excluding one-time items other than stock-based compensation
expenses) loss per share from continued operation of 4 cents missed
the Zacks Consensus Estimate of earnings of
9 cents per share.
However, the North Carolina-based company turned to profit (on a
reported basis) in the quarter riding on gains associated with
asset sales. MedCath posted a net income of $12.3 million (or 61
cents a share) in the third quarter compared with a loss of $12.8
million (or 64 cents a share) a year-ago.
On a continuing operation basis, the company booked a net loss
of $3.1 million (or 15 cents per share) versus a loss of $14.8
million (or 74 cents per share) in the earlier year quarter.
Revenues inched down 1.4% year over year to $91.8 million, but
were higher than the Zacks Consensus Estimate of $72 million. Total
hospital admissions dipped 1.2% year over year in the quarter to
4,779. Hospital outpatient cases climbed 8.6% year over year to
15,493.
MedCath exited the quarter with cash and
cash equivalents of $113.7 million, more than a four-fold
year over year increase. The company used the proceeds (of $29.8
million) from assets sales along with cash on
hand to repay debt worth $30.2 million during the third
quarter.
MedCath provides high acuity health care services and operates 4
hospitals with a total of 366 licensed beds. It owns and operates
specialty hospitals that provide diagnosis and treatment of
cardiovascular diseases.
The company, on August 1, 2011, completed the sale of its equity
interest in Arkansas Heart Hospital and divested substantially all
the assets of Heart Hospital of New Mexico. Results of these
entities are included in the third quarter report. MedCath expects
net proceeds from these transactions to be roughly $122
million.
MEDCATH CORP (MDTH): Free Stock Analysis Report
Zacks Investment Research
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024